Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1158 | Male Reproduction | ECE2017

After 9 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (December 2016)

Pisoschi Matei

Aim: Has testosterone undecanoat 1000 mg injection (NebidoR; Bayer), 1/3month negative effect on prostate?Material and method: i) PSA (ng/ml) was registred retrospective (from files) and prospective analysis (onset 2010). ii) Patients: PSA analysis was done before treatment and recorded at T1 to T12 [2 weeks to 9 years] (see Pisoschi, this Congress). iii) Statistical analysis: Student test, simple correlation, multiple regression.<p class=...

ea0049ep1157 | Male Reproduction | ECE2017

Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume. Study during up to 9 years on hypogonadic patients. (December 2016)

Pisoschi Matei , Cristina Staicu Dana , Peretianu Dan

Aim: Re-analyzing (study starting in 2007) the effect of injectable testosterone undecanoat depot (TUD) in hypogonadic patients.Materials and Methods: A. Patients: at onset 231 men with hypogonadism (median: 62 y). B. Distribution: by decade (starting with 20y); no =4, 14, 24, 61, 63, 49, 17, 1. C. TUD (NebidoR-Bayer) 1000 mg injected one/3 months i.m. D. Prostate volume (PV) appreciated by per-abdominal ultrasound: 3.5–5 MHz probe, ellip...

ea0032p662 | Male reproduction | ECE2013

Testosterone undecanoate 1000 mg at 3 months does not increase prostatic specific antigen level: study on over 100 patients, December 2012

Pisoschi Matei , Cristina Staicu Daniela , Peretianu Dan

Aim: To find if testosterone undecanoat 1000 mg injection (Nebido; Bayer-Schering) has a negative effect on prostate.Materials and methods: i) PSA (ng/ml) was registred retrospective (from files) and prospective analysis (onset 2010). ii) From over 175 patients to whom testosterone undecanoate 1000 mg, i.m. was administrated at 3 months, in the last 4 years, and to whom the prostatic volume was quantified (Journal of Sexual Medicine8</st...

ea0063p301 | Reproductive Endocrinology 1 | ECE2019

After up to 11 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (January 2019)

Pisoschi Matei , Staicu Dana Cristina , Peretianu Dan , Oprisan Bogdan

Aim: Has testosterone undecanoat 1000 mg intramuscular injection (NebidoR; Bayer), 1 at 3month, negative effect on prostate? For this purpose, we appreciate the prostatic volume (see Pisoschi, this congress) and PSA (this study) in hypogonadic patients after testosterone injection up to 11 years.Material and method: A. PSA (ng/ml) was done in Bucharest accredited laboratories.B. Patients: PSA analysis was done before tre...

ea0063p302 | Reproductive Endocrinology 1 | ECE2019

Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: Study during up to 11 years on hypogonadic patients. (January 2019)

Pisoschi Matei , Staicu Dana Cristina , Peretianu Dan , Oprisan Bogdan

Aim: Re-Analysing (study starting in 2007) the effect of injectable testosterone undecanoat depot (TUD) in hypogonadic patients.Material-method: A. Patients: at onset 278 men with hypogonadism (median: 61 y).B. Distribution: by decade (starting with 20y); no =6, 17, 25, 70, 86, 55, 18, 1.C. TUD (NebidoR-Bayer) 1000 mg injected one/3 months i.m.D. Prostate volume (PV) apprecia...

ea0073aep607 | Reproductive and Developmental Endocrinology | ECE2021

Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume. Study during up to 13 years on hypogonadic patients. (January 2021)

Peretianu Dan , Pisoschi Matei , Stanciu Mihaela , Oprisan Bogdan

AimRe-Analysing (starting 2007) the effect of injectable testosterone undecanoat depot (TUD) in hypogonadic patients.Material-methodA. Patients: at onset 333 men with hypogonadism (median: 62 y).B. Distribution: by decade (starting with 20y->90y); no = 6, 18, 35, 80, 104, 67, 21, 2.C. TUD (Neb...

ea0073aep608 | Reproductive and Developmental Endocrinology | ECE2021

After up to 13 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level. Relation with prostatic volume (January 2021)

Pisoschi Matei , Stanciu Mihaela , Peretianu Dan , Oprisan Bogdan

AimWe appreciate the effect of testosterone undecanoat 1000 mg intramuscular injection (NebidoR; Bayer) on both prostatic volume (see Peretianu, this congress) and PSA (this study) in hypogonadic patients after up to 13 years.Material and methodA. PSA (ng/ml) was done in Bucharest accredited laboratories, appreciated at 1 year. B. Prostatic volume (PV): ultrasound,...

ea0037ep145 | Reproduction, endocrine disruptors and signalling | ECE2015

Analysing by decade, testosterone undecanoate depot injectable does not increase prostate volume: study during up to 7 years on hypogonadic patients

Pisoschi Matei , Carsote Mara , Poiana Catalina , Staicu Dana Cristina , Peretianu Dan

Aim: Re-analysing the effect of injectable testosterone undecanoate depot (TUD) in hypogonadic patients.Materials and method: (A) Patients: at onset 210 men with hypogonadism (median age: 61.5 years). (B) Distribution: by decade; n=4, 12, 21, 54, 59, 43, 16, and 1. (C) TUD (NebidoR-Bayer-Schering) 1000 mg was injected one per 3 months i.m. (D) Prostate volume (PV) appreciated by per-abdominal ultrasound: 3.5 MHz probe, elliptical volume (cm...

ea0037ep146 | Reproduction, endocrine disruptors and signalling | ECE2015

Testosterone undecanoate 1000 mg at 3 months did not increased prostatic specific antigen level: January 2015

Pisoschi Matei , Carsote Mara , Poiana Catalina , Staicu Dana Cristina , Peretianu Dan

Aim: To find if testosterone undecanoate (TUD) 1000 mg injection (NebidoR; Bayer-Schering) at 3 months has a negative effect on prostate.Materials and method: i) PSA (ng/ml) registred before (T0) and after TUD at T1 (2 weeks) to T10 (7 years) (see Pisoschi, this Congress); ii) statistical analysis: t-test, simple correlation, and multiple regression.Results: (A) Patients at onset: 143 men, 18–96 years, average: 60.38;...

ea0035p689 | Male reproduction | ECE2014

Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: study during up to 6 years on hypogonadic patients

Pisoschi Matei , Carsote Mara , Poiana Catalina , Staicu Cristina Daniela , Peretianu Dan

Aim: Re-analyzing the effect of injectable testosterone undecanoat depot (TUD) in hypogonadic patients.Materials & methods: (A) Patients: at onset 191 men with hypogonadism (median age: 64 years). (B) Distribution: by decade. (C) TUD (NebidoR-Bayer-Schering) 1000 mg was injected one per 3 months i.m. (D) Prostate volume (PV) by per-abdominal ultrasound: 3.5 MHz probe, elliptical volume (cm3), Aloka 550. (E). Time of analysis: be...